Cargando…
Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
Background: Chemotherapy is the main treatment for triple-negative breast cancer (TNBC), which lack molecular markers for diagnosis and therapy. Cancer cells activate chemoresistant pathways and lead to therapeutic failure for patients with TNBC. Several kinases have been identified as chemoresistan...
Autores principales: | Tzeng, Yen-Dun Tony, Liu, Pei-Feng, Li, Ju-Yueh, Liu, Li-Feng, Kuo, Soong-Yu, Hsieh, Chiao-Wei, Lee, Cheng-Hsin, Wu, Chih-Hsuan, Hsiao, Michael, Chang, Hong-Tai, Shu, Chih-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238227/ https://www.ncbi.nlm.nih.gov/pubmed/30473665 http://dx.doi.org/10.3389/fphar.2018.01285 |
Ejemplares similares
-
Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells
por: Chang, Chia-Che, et al.
Publicado: (2021) -
Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling
por: Lu, Yiling, et al.
Publicado: (2011) -
Src signaling in a low-complexity unicellular kinome
por: Suga, Hiroshi, et al.
Publicado: (2018) -
High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation
por: Azorsa, David O, et al.
Publicado: (2010) -
Characterization of the Src-regulated kinome identifies SGK1 as a key mediator of Src-induced transformation
por: Ma, Xiuquan, et al.
Publicado: (2019)